Last reviewed · How we verify

NCT04601636: PREWARMING

Comparison of Active Prewarming Versus Standard Care to Prevent Perioperative Hyporthermia in Short Outpatient Surgery Under General Anesthesia

Completed NA Last updated 4 October 2021
What this trial tests

NA trial testing Active Prewarming in Hypothermia Following Anesthesia in 60 participants. Completed in 31 May 2021.

Timeline
26 October 2020
Primary endpoint
31 January 2021
31 May 2021

Quick facts

Lead sponsorCiusss de L'Est de l'Île de Montréal
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment60
Start date26 October 2020
Primary completion31 January 2021
Estimated completion31 May 2021
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Ciusss de L'Est de l'Île de Montréal — full company profile →

Who can join

18 and older, any sex, with Hypothermia Following Anesthesia or Hypothermia, Accidental. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this prospective randomized controlled study is to compare the efficiency in preventing perioperative hypothermia of a continuous active prewarming combined with active intraoperative warming versus passive prewarming plus intraoperative warming for short outpatient surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypothermia Following Anesthesia

Currently open trials in the same condition.

Other Ciusss de L'Est de l'Île de Montréal trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04601636.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing